(Q408801)

celecoxib (English)

18 November 2016

C₁₇H₁₄F₃N₃O₂S

1 reference

celecoxib (English)

18 November 2016

CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F

1 reference

celecoxib (English)

18 November 2016

0.2 gram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=M01AH01

active ingredient in

Onsenal

1 reference

European Medicines Agency product number

EMEA/H/C/000466

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000466/human_med_000948.jsp

22 March 2017

1 reference

14 February 2018

World Health Organisation international non-proprietary name

celecoxib (English)

1 reference

celecoxib (English)

medical condition treated

19 October 2016

1 reference

13 December 2016

1 reference

familial adenomatous polyposis

13 December 2016

1 reference

13 December 2016

1 reference

osteoarthritis susceptibility 1

13 December 2016

1 reference

2 October 2018

ankylosing spondylitis

1 reference

2 October 2018

fibromyalgia

1 reference

2 October 2018

arthropathy

1 reference

2 October 2018

arthritis

1 reference

2 October 2018

spondylitis

1 reference

significant drug interaction

2 October 2018

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clopidogrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eptifibatide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

iloprost

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prostacyclin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tirofiban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

abciximab

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prasugrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ticagrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cangrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fondaparinux

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenindione

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

budesonide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bumetanide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

furosemide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methotrexate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenofovir disoproxil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

bone marrow failure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

gastrointestinal toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bumetanide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

furosemide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

budesonide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenofovir disoproxil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Carbonic anhydrase 12

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Prostaglandin-endoperoxide synthase 2

17 August 2016

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

17 August 2016

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category B3

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category B

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Celecoxib

last update

23 January 2017

subject has role

cyclooxygenase inhibitors

1 reference

5 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D000068579

non-steroidal anti-inflammatory drug

15 March 2018

1 reference

27 February 2018

CeleBREX

Institute for Safe Medication Practices

1 reference

https://www.ismp.org/recommendations/tall-man-letters-list

InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)

2 September 2022

Commons category

Celecoxib

0 references

Identifiers

InChI

1 reference

RZEKVGVHFLEQIL-UHFFFAOYSA-N

celecoxib (English)

18 November 2016

2 references

celecoxib (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

169590-42-5

2 references

RZEKVGVHFLEQIL-UHFFFAOYSA-N

celecoxib (English)

18 November 2016

8 April 2021

https://commonchemistry.cas.org/detail?cas_rn=169590-42-5

1 reference

Celecoxib (English)

18 November 2016

1 reference

celecoxib (English)

18 November 2016

Reaxys registry number

8280770

1 reference

celecoxib (English)

19 October 2016

mapping relation type

1 reference

CELECOXIB (English)

18 November 2016

1 reference

MSBNK-Athens_Univ-AU235657

CELECOXIB (English)

18 November 2016

1 reference

MassBank accession ID

SM851602

0 references

SM851653

0 references

0 references

MSBNK-Athens_Univ-AU235658

0 references

MSBNK-Athens_Univ-AU235659

0 references

MSBNK-Athens_Univ-AU235660

0 references

SPLASH

splash10-001i-0029000000-13ff69b3abd31dde6bae

0 references

splash10-001i-0029000000-1a5ed66ff895eeb127ce

0 references

HSDB ID

7038

1 reference

Hazardous Substances Data Bank

28 October 2019

Celecoxib (English)

10 May 2021

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

0 references

685-962-5

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.211.644

27 December 2018

ECHA Substance Infocard ID

4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide (English)

quotation

CAS no.: 169590-42-5 (English)

100.211.644

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.211.644

27 December 2018

4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide (English)

quotation

CAS no.: 169590-42-5 (English)

1 reference

Celecoxib (English)

17 November 2015

1 reference

Celecoxib (English)

publication date

17 November 2015

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

D02.455.426.559.389.085.020

celecoxib (English)

18 November 2016

Celecoxib

0 references

0 references

0 references

0 references

0 references

D02.886.590.700.090.020

0 references

RxNorm ID

140587

1 reference

celecoxib (English)

18 November 2016

1 reference

Celecoxib (English)

Human Metabolome Database ID

18 November 2016

0 references

1 reference

celecoxib (English)

MedlinePlus drug identifier

18 November 2016

a699022

0 references

PatientsLikeMe treatment ID

0 references

1 reference

celecoxib (English)

18 November 2016

0 references

0 references

1 reference

1 reference

Immune Epitope Database and Analysis Resource

Celecoxib (English)

19 January 2016

1 reference

1 March 2022

0 references

0 references

Encyclopædia Britannica Online ID

topic/Celebrex

subject named as

Celebrex

reason for deprecated rank

withdrawn identifier value

0 references

1 reference

28 October 2013

Microsoft Academic ID

2776467144

0 references

New York Times topic ID

subject/celebrex-drug

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

1OQ5 (English)

19 October 2016

1 reference

3LN1 (English)

19 October 2016

1 reference

3KK6 (English)

19 October 2016

1 reference

4FIM (English)

Store medisinske leksikon ID

19 October 2016

0 references

1 reference

inferred by common MeSH mappings on source and on Wikidata

celecoxib (English)

18 November 2016

1 reference

25 May 2023

0 references

WordNet 3.1 Synset ID

02994016-n

1 reference